Expand URGN Menu
URGN MENU

URGN Stock Posts


URGN stock declines -5.4% in premarket,

Premarket Decliner

URGN Urogen Pharma Ltd. -14.51-0.15-1.0%

Premarket:13.72-0.79 (-5.4%)

UroGen Pharma Ahead of Schedule to Complete UGN-102 NDA Submission and Reports 2024 Second Quarter Financial Results and Business Highlights

Business WireTue, 13-Aug 8:00 AM

URGN stock declines -4.4% in premarket,

Premarket Decliner

URGN Urogen Pharma Ltd. -18.28-0.92-4.8%

Premarket:17.48-0.80 (-4.4%)

UroGen Pharma Announces Pricing of Public Offering of Ordinary Shares and Pre-Funded Warrants

Business WireMon, 17-Jun 10:51 PM

URGN stock declines -3.6% in after hours trading. See the latest news.

After Hours Decliner

URGN Urogen Pharma Ltd. -18.28-0.92-4.8%

After Hours:17.63-0.65 (-3.6%)

UroGen Pharma Announces Commencement of Public Offering of Ordinary Shares and Pre-Funded Warrants

Globe NewswireMon, 17-Jun 4:46 PM

Unusual Option Volume

URGN Urogen Pharma Ltd. -18.82+1.32 (+7.5%)

Urogen Pharma Ltd. - trades 2,481 contracts.
Unusual Option Volume

URGN Urogen Pharma Ltd. -17.87+5.15 (+40.5%)

Urogen Pharma Ltd. - trades 2,628 contracts. The company has the following event: UGN-102 Virtual Data Event on Jun 13, 2024. News: UroGen Announces Unprecedented 82.3% Duration of Response at 12 Months in the ENVISION Trial Investigating UGN-102 as Potentially the First FDA-Approved Non-Surgical Treatment for LG-IR-NMIBC
Unusual Option Volume

URGN Urogen Pharma Ltd. -19.86+1.97 (+11.0%)

Urogen Pharma Ltd. - trades 3,760 contracts.